{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:04:00Z","timestamp":1784837040551,"version":"3.55.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405311"],"award-info":[{"award-number":["82405311"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing University of Chinese Medicine Dongzhimen Hospital","award":["2024-JYB-JBZD-003"],"award-info":[{"award-number":["2024-JYB-JBZD-003"]}]},{"name":"Beijing University of Chinese Medicine Dongzhimen Hospital","award":["DZMKJCX-2024-005"],"award-info":[{"award-number":["DZMKJCX-2024-005"]}]},{"name":"Central-level High-Quality Traditional Chinese Medicine Hospital Clinical Research and Business Expense Funding","award":["DZMG-LJRC005"],"award-info":[{"award-number":["DZMG-LJRC005"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The global prevalence of diabetes mellitus (DM) has risen markedly, with patients facing a substantially higher risk of atherosclerotic cardiovascular disease (ASCVD) and related mortality. Although lipid-modifying agents, including statins, fibrates, cholesterol absorption inhibitors, proprotein convertase subtilisin\/kexin type 9 inhibitors (PCSK9i), bromodomain and extra-terminal motif inhibitors (BETi), and adenosine triphosphate-citrate lyase inhibitors (ACLi) continue to emerge, their comparative efficacy and safety in patients with DM remain uncertain. This study aims to address this gap through a comprehensive network meta-analysis (NMA) of randomized controlled trials (RCTs) evaluating cardiovascular outcomes, lipid-modifying efficacy, and safety among these therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>A systematic search will be performed in PubMed, Web of Science, Scopus, the Cochrane Central Register of Controlled Trials (CENTRAL), Embase (via Ovid), International Clinical Trials Registry Platform (ICTRP) and ClinicalTrials.gov from inception, without language or regional restrictions. Eligible studies will include parallel-design RCTs comparing monotherapy or combination therapy. The primary outcome will be cardiovascular events (composite and individual), and secondary outcomes will include cardiac biomarkers, ASCVD risk scores, lipid parameters (TC, LDL-C, HDL-C, TG) and safety outcomes. Two reviewers will independently conduct study selection, data extraction, and quality assessment using the Cochrane Risk of Bias 2 (RoB 2.0) tool, with evidence certainty evaluated via the Confidence in Network Meta-Analysis (CINeMA) framework. Data will be standardized where appropriate, and analyses, including assessment of publication bias, will be conducted using Stata 18 and R. The protocol is registered with PROSPERO, and findings will be disseminated through peer-reviewed publication.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Registration:<\/jats:bold>\n                      PROSPERO CRD420251163974.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0354259","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:14:13Z","timestamp":1784834053000},"page":"e0354259","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid-modifying pharmacotherapy in diabetes mellitus: A protocol for a systematic review and network meta-analysis of randomised trials"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7450-7273","authenticated-orcid":true,"given":"Xudong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuijuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruigeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushang","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"pone.0354259.ref001","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"K Ogurtsova","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"pone.0354259.ref002","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"pone.0354259.ref003","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/qjmed\/hcp121","article-title":"Early onset type 2 diabetes mellitus: a harbinger for complications in later years--clinical observation from a secondary care cohort","volume":"102","author":"SH Song","year":"2009","journal-title":"QJM"},{"issue":"11","key":"pone.0354259.ref004","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2337\/diacare.26.11.2999","article-title":"Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth","volume":"26","author":"TA Hillier","year":"2003","journal-title":"Diabetes Care"},{"issue":"7","key":"pone.0354259.ref005","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.298.7.765","article-title":"Diabetes and mortality following acute coronary syndromes","volume":"298","author":"SM Donahoe","year":"2007","journal-title":"JAMA"},{"key":"pone.0354259.ref006","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)","volume":"44","author":"N Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"pone.0354259.ref007","volume-title":"Guidelines for the Management of High Blood Cholesterol","author":"KR Feingold","year":"2025"},{"issue":"9841","key":"pone.0354259.ref008","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Cholesterol Treatment Trialists\u2019 (CTT) Collaborators","year":"2012","journal-title":"Lancet"},{"key":"pone.0354259.ref009","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"SM Grundy","year":"2018","journal-title":"Circulation"},{"key":"pone.0354259.ref010","article-title":"Focused update of the 2019 ESC\/EAS guidelines for the management of dyslipidaemias: Developed by the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"190","author":"F Mach","year":"2025","journal-title":"Eur Heart J"},{"issue":"1","key":"pone.0354259.ref011","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"F Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"8","key":"pone.0354259.ref012","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/CIR.0000000000000230","article-title":"Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association","volume":"132","author":"CS Fox","year":"2015","journal-title":"Circulation"},{"issue":"39","key":"pone.0354259.ref013","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"F Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"issue":"16","key":"pone.0354259.ref014","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/eurheartj\/ehac822","article-title":"Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality","volume":"44","author":"BN Wadstr\u00f6m","year":"2023","journal-title":"Eur Heart J"},{"issue":"16","key":"pone.0354259.ref015","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications","volume":"116","author":"I Tabas","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"pone.0354259.ref016","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","article-title":"The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity","volume":"27","author":"J Bor\u00e9n","year":"2016","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"pone.0354259.ref017","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4103\/2230-8210.113753","article-title":"Journey in guidelines for lipid management: From adult treatment panel (ATP)-I to ATP-III and what to expect in ATP-IV","volume":"17","author":"PG Talwalkar","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"issue":"2","key":"pone.0354259.ref018","doi-asserted-by":"crossref","first-page":"25882","DOI":"10.31083\/RCM25882","article-title":"Effects of n-3 Polyunsaturated Fatty Acid Supplementation on Cardiovascular Indices in Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials","volume":"26","author":"R Li","year":"2025","journal-title":"Rev Cardiovasc Med"},{"issue":"4","key":"pone.0354259.ref019","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ehjcvp\/pvad019","article-title":"The efficacy of PCSK9 inhibitors on major cardiovascular events and lipid profile in patients with diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"E Imbalzano","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"pone.0354259.ref020","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-067731","article-title":"Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis","volume":"376","author":"A Hodkinson","year":"2022","journal-title":"BMJ"},{"key":"pone.0354259.ref021","doi-asserted-by":"crossref","first-page":"117187","DOI":"10.1016\/j.atherosclerosis.2023.117187","article-title":"Triglyceride-lowering therapy for the prevention of cardiovascular events, stroke, and mortality in patients with diabetes: A meta-analysis of randomized controlled trials","volume":"394","author":"XH Yang","year":"2024","journal-title":"Atherosclerosis"},{"issue":"11","key":"pone.0354259.ref022","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.numecd.2022.07.018","article-title":"Statin use and the risk of CVD events, stroke, and all-cause mortality in patients with diabetes: A systematic review and meta-analysis","volume":"32","author":"XH Yang","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"pone.0354259.ref023","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12020-023-03401-y","article-title":"Benefits and harms of fibrate therapy in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"81","author":"R Rodriguez-Gutierrez","year":"2023","journal-title":"Endocrine"},{"issue":"2","key":"pone.0354259.ref024","doi-asserted-by":"crossref","first-page":"25882","DOI":"10.31083\/RCM25882","article-title":"Effects of n-3 Polyunsaturated Fatty Acid Supplementation on Cardiovascular Indices in Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials","volume":"26","author":"R Li","year":"2025","journal-title":"Rev Cardiovasc Med"},{"issue":"4","key":"pone.0354259.ref025","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.advnut.2023.04.009","article-title":"Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Outcomes in Patients with Diabetes: A Meta-analysis of Randomized Controlled Trials","volume":"14","author":"L Huang","year":"2023","journal-title":"Adv Nutr"},{"issue":"4","key":"pone.0354259.ref026","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ehjcvp\/pvad019","article-title":"The efficacy of PCSK9 inhibitors on major cardiovascular events and lipid profile in patients with diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"E Imbalzano","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"1","key":"pone.0354259.ref027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"D Moher","year":"2015","journal-title":"Syst Rev"},{"key":"pone.0354259.ref028","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"L Shamseer","year":"2015","journal-title":"BMJ"},{"key":"pone.0354259.ref029","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jclinepi.2016.11.015","article-title":"Additional considerations are required when preparing a protocol for a systematic review with multiple interventions","volume":"83","author":"A Chaimani","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"pone.0354259.ref030","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"MJ Page","year":"2021","journal-title":"BMJ"},{"issue":"11","key":"pone.0354259.ref031","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"B Hutton","year":"2015","journal-title":"Ann Intern Med"},{"issue":"24","key":"pone.0354259.ref032","first-page":"3153","article-title":"Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology","volume":"73","author":"DM Lloyd-Jones","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"pone.0354259.ref033","author":"American College of Cardiology","year":"2025"},{"issue":"6","key":"pone.0354259.ref034","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"WT Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"19","key":"pone.0354259.ref035","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile","volume":"310","author":"SS Martin","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"pone.0354259.ref036","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","article-title":"A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and\/or Hypertriglyceridemia","volume":"5","author":"M Sampson","year":"2020","journal-title":"JAMA Cardiol"},{"key":"pone.0354259.ref037","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"JAC Sterne","year":"2019","journal-title":"BMJ"},{"key":"pone.0354259.ref038","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"X Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"pone.0354259.ref039","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"D Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"pone.0354259.ref040","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024)","author":"JPT Higgins","year":"2024"},{"issue":"2","key":"pone.0354259.ref041","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"JPT Higgins","year":"2012","journal-title":"Res Synth Methods"},{"issue":"5","key":"pone.0354259.ref042","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/0272989X12455847","article-title":"Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials","volume":"33","author":"S Dias","year":"2013","journal-title":"Med Decis Making"},{"issue":"4","key":"pone.0354259.ref043","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jrsm.1058","article-title":"Network meta-analysis, electrical networks and graph theory","volume":"3","author":"G R\u00fccker","year":"2012","journal-title":"Res Synth Methods"},{"issue":"2","key":"pone.0354259.ref044","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"G Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"pone.0354259.ref045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12874-025-02754-4","article-title":"Network meta-analysis with dose-response relationships","volume":"26","author":"M Petropoulou","year":"2026","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"pone.0354259.ref046","article-title":"CINeMA: Software for semiautomated assessment of the confidence in the results of network meta-analysis","volume":"16","author":"T Papakonstantinou","year":"2020","journal-title":"Campbell Syst Rev"},{"issue":"4","key":"pone.0354259.ref047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: An approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"A Nikolakopoulou","year":"2020","journal-title":"PLoS Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:14:21Z","timestamp":1784834061000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354259"}},"subtitle":[],"editor":[{"given":"Paolo","family":"Magni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":47,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0354259","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}